Various approaches are used to integrate the desired genes encoding the antigen protein for a given illness into the genome of plant tissues in plant-based vaccination technology. Gene transfer by agrobacterium and transformation via a genetically engineered plant virus are two typical approaches for producing efficient vaccinations. Antibodies are an important component of vertebrates' adaptive immune systems, and they may now be made by converting plants with antibody-coding genes from animals and humans. Despite the fact that plants do not produce antibodies naturally, plant-derived antibodies (plantibodies) have been proven to behave similarly to mammalian antibodies. However, as science and technology have progressed, new approaches have been created to improve the efficiency of older technologies including biolistic, electroporation, agroinfiltration, sonication, and polyethylene glycol treatment. Despite the fact that plant-based vaccinations have numerous advantages for the vaccine industry, there are still constraints that limit the rate at which these third-generation vaccines may be successfully manufactured. Despite these limitations, continued attempts are still underway to develop effective vaccines for a variety of human and animal diseases, owing to its enormous potential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.